NASDAQ:HSICHenry Schein Stock Price, Forecast & News

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HSIC shares have increased by 6.0% and is now trading at $61.13. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Henry Schein.

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Henry Schein.

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, May, 5th. The company reported $0.94 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.20. The company earned $2.43 billion during the quarter, compared to analyst estimates of $2.32 billion. Henry Schein had a net margin of 7.11% and a return on equity of 15.19%. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.80 EPS. View Henry Schein's earnings history.

Shares of Henry Schein split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has authorized a stock repurchase program on Thursday, October 31st 2019, which authorizes the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

14 analysts have issued 12 month price targets for Henry Schein's stock. Their forecasts range from $50.00 to $80.00. On average, they anticipate Henry Schein's stock price to reach $63.73 in the next year. This suggests a possible upside of 4.2% from the stock's current price. View analysts' price targets for Henry Schein.

Headlines about HSIC stock have trended very positive recently, according to InfoTrie. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Henry Schein earned a media sentiment score of 3.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutHenry Schein.

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), AbbVie (ABBV), AT&T (T), Walt Disney (DIS), Pfizer (PFE), Intel (INTC), NVIDIA (NVDA), salesforce.com (CRM), Cisco Systems (CSCO) and UnitedHealth Group (UNH).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by many different institutional and retail investors. Top institutional investors include Longview Partners Guernsey LTD (10.22%), BlackRock Inc. (8.41%), State Street Corp (5.36%), Mackenzie Financial Corp (2.30%), Atlanta Capital Management Co. L L C (1.90%) and JPMorgan Chase & Co. (1.87%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Mark E Mlotek, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View institutional ownership trends for Henry Schein.

HSIC stock was sold by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., AMI Asset Management Corp, Boston Trust Walden Corp, Mackenzie Financial Corp, and Boston Trust Walden Corp. Company insiders that have sold Henry Schein company stock in the last year include E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel. View insider buying and selling activity for Henry Schein.

HSIC stock was purchased by a variety of institutional investors in the last quarter, including Sound Shore Management Inc. CT, BlackRock Inc., Fiduciary Management Inc. WI, AXA, State of Tennessee Treasury Department, Acadian Asset Management LLC, Bank of New York Mellon Corp, and New York State Common Retirement Fund. View insider buying and selling activity for Henry Schein.

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $61.13.

Henry Schein has a market capitalization of $8.73 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

The official website for Henry Schein is www.henryschein.com.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]